Home

The Korea Herald

Latest news

Most Popular

  1. 1

    NewJeans to terminate contract with Ador

    NewJeans to terminate contract with Ador
  2. 2

    Korean Air gets European nod to become Northeast Asia’s largest airline

    Korean Air gets European nod to become Northeast Asia’s largest airline
  3. 3

    NewJeans terminates contract with Ador, embarks on new journey

    NewJeans terminates contract with Ador, embarks on new journey
  4. 4

    Seoul snowfall now third heaviest on record

    Seoul snowfall now third heaviest on record
  5. 5

    Heavy snow of up to 40 cm blankets Seoul for 2nd day

    Heavy snow of up to 40 cm blankets Seoul for 2nd day
  1. 6

    Chaos unfolds as rare November snowstorm grips Korea for 2nd day

    Chaos unfolds as rare November snowstorm grips Korea for 2nd day
  2. 7

    BOK makes surprise 2nd rate cut to boost growth

    BOK makes surprise 2nd rate cut to boost growth
  3. 8

    ‘VCHA, Katseye and Dear Alice are not K-pop groups,’ industry experts say

    ‘VCHA, Katseye and Dear Alice are not K-pop groups,’ industry experts say
  4. 9

    [Graphic News] South Koreans favor Japan for repeat overseas trips

    [Graphic News] South Koreans favor Japan for repeat overseas trips
  5. 10

    Ador claims exclusive contracts with NewJeans still valid

    Ador claims exclusive contracts with NewJeans still valid
피터빈트

Prosecutors raid Seoul bourse in Samsung BioLogics probe

By Yonhap

Published : March 15, 2019 - 10:15

    • Link copied

Prosecutors raided South Korea's main stock exchange Friday as part of a probe into alleged accounting fraud by Samsung BioLogics Co.

Investigators from the Seoul Central District Prosecutors' Office were sent to search the Korea Exchange in western Seoul.

They also raided the offices of two Samsung units -- Samsung S&T Corp. and Samsung SDS Co. -- on Thursday in the probe into the biopharmaceutical company. 


(Yonhap) (Yonhap)

Prosecutors are investigating allegations that Samsung BioLogics Co. broke accounting rules in inflating the value of its subsidiary, Samsung Bioepis, ahead of BioLogics' 2016 initial public offering.

The prosecution suspects the KRX eased the IPO rules at that time to make BioLogics eligible for listing on the tech-heavy KOSDAQ market.

The Financial Services Commission judged in its own inquiry that the alleged fraudulent accounting possibly amounts to 4.5 trillion won ($3.96 billion).

Civic groups claimed the alleged fraud was aimed at enhancing heir apparent Lee Jae-yong's control of Samsung Group. (Yonhap)

More from Headlines